« Back to Record
Lalami, Y., Garcia, C., Flamen, P., Ameye, L., Paesmans, M., & Awada, A. (2016). Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer. Head & neck, 38(3), 347-354. doi:10.1002/hed.23898
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231589



